D'AGOSTINO, Mattia
D'AGOSTINO, Mattia
BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells
2024-01-01 D'Agostino, Mattia; Rota-Scalabrini, Delia; Belotti, Angelo; Bertamini, Luca; Arigoni, Maddalena; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Pisani, Francesco; Pescosta, Norbert; Ruggeri, Marina; Rogers, Jennifer; Olivero, Martina; Garzia, Mariagrazia; Galieni, Piero; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Stefanoni, Paola; Zamagni, Elena; Bruno, Benedetto; Calogero, Raffaele Adolfo; Boccadoro, Mario; Musto, Pellegrino; Gay, Francesca
Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies
2024-01-01 Richardson, Paul G.; Perrot, Aurore; Mikhael, Joseph; Martin, Thomas; Beksac, Meral; Spicka, Ivan; Capra, Marcelo; D'Agostino, Mattia; Sonneveld, Pieter; Bisht, Kamlesh; Fukao, Taro; Zhang, Rick; Tada, Keisuke; Tekle, Christina; Macé, Sandrine; Klippel, Zandra; van de Velde, Helgi; Moreau, Philippe
Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better?
2020-01-01 D'Agostino M.; Raje N.
Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?
2020-01-01 D'Agostino M.; Mina R.; Gay F.
Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo
2019-01-01 Mattia D'Agostino; Mario Boccadoro
Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial
2025-01-01 Bringhen, Sara; Cani, Lorenzo; Giuliani, Nicola; Mangiacavalli, Silvia; Benevolo, Giulia; Antonioli, Elisabetta; Zambello, Renato; Ria, Roberto; Vincelli, Iolanda Donatella; Ronconi, Sonia; More, Sonia; Falcone, Antonietta Pia; Allegra, Alessandro; D'Agostino, Mattia; Evangelista, Andrea; Capra, Andrea; Sciorsci, Elisa; Curci, Paola; Tosi, Patrizia; Liberati, Anna Marina; Cafro, Anna Maria; Belotti, Angelo; Patriarca, Francesca; Mannina, Donato; Mancuso, Katia; Cattel, Francesco; Ciccone, Giovannino; Bruno, Benedetto; Boccadoro, Mario; Larocca, Alessandra
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
2021-01-01 Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
Carfilzomib–lenalidomide–dexamethasone versus lenalidomide–dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial
2025-01-01 Bringhen, Sara; Cani, Lorenzo; Antonioli, Elisabetta; Derudas, Daniele; Fazio, Francesca; Larocca, Alessandra; Ronconi, Sonia; Cellini, Claudia; Falcone, Antonietta Pia; Accardi, Fabrizio; Liberati, Anna Marina; Galieni, Piero; Belotti, Angelo; Cafro, Anna Maria; Ria, Roberto; Benevolo, Giulia; Vincelli, Iolanda Donatella; Mannina, Donato; Lotti, Flavia; Bruno, Benedetto; Marasco, Vincenzo; Mazza, Rita; Tosi, Patrizia; Rivolti, Elena; Boccadoro, Mario; D'Agostino, Mattia
CD38 as an immunotherapeutic target in multiple myeloma
2018-01-01 Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F.
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino
2019-01-01 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone
2025-01-01 Bertamini, Luca; Fokkema, Cathelijne; Rodriguez-Otero, Paula; van Duin, Mark; Terpos, Evangelos; D'Agostino, Mattia; van der Velden, Vincent H.J.; van de Donk, Niels W.C.J.; Delforge, Michel; Driessen, Christoph; Hajek, Roman; Einsele, Hermann; Vangsted, Annette Juul; Vieyra, Diego; Attar, Ricardo M; Sitthi-Amorn, Anna; Carson, Robin; Schjesvold, Fredrik; Robak, Pawel; Beksac, Meral; Spencer, Andrew; Broijl, Annemiek; Cupedo, Tom; Moreau, Philippe; Boccadoro, Mario; Sonneveld, Pieter
Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma
2019-01-01 D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F.
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
2020-01-01 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Clinicians’ Perspectives and Methodological Application of Fluorescence in Situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report from the European Myeloma Network (EMN) Italy
2025-01-01 Cani, Lorenzo; Petrucci, Maria Teresa; Mancuso, Katia; Zambello, Renato; Paris, Laura; Aquino, Sara; Lotti, Flavia; Vassallo, Francesco; Pescosta, Norbert; Quaresima, Micol; Tosi, Patrizia; Vincelli, Iolanda Donatella; Ronconi, Sonia; Giuliani, Nicola; Pisani, Francesco; Luppi, Mario; Rizzi, Rita; Mazza, Rita; Rota-Scalabrini, Delia; Cellini, Claudia; Mangiacavalli, Silvia; Pietrantuono, Giuseppe; Pioltelli, Maria Luisa; Falcone, Antonietta Pia; Antonioli, Elisabetta; Belotti, Angelo; Morè, Sonia; Bruno, Benedetto; Boccadoro, Mario; D'Agostino, Mattia
Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes
2024-01-01 Skerget, Sheri; Penaherrera, Daniel; Chari, Ajai; Jagannath, Sundar; Siegel, David S.; Vij, Ravi; Orloff, Gregory; Jakubowiak, Andrzej; Niesvizky, Ruben; Liles, Darla; Berdeja, Jesus; Levy, Moshe; Wolf, Jeffrey; Usmani, Saad Z.; null, null; Rifkin, Robert; Meehan, Kenneth; Benson, Don; Zonder, Jeffrey; Ascensao, Joao; Gasparetto, Cristina; Hernández, Miguel; Trudel, Suzanne; Dakhil, Shaker; Bahlis, Nizar; Paganini, Juan Vazquez; Rios, Pablo; Sampol, Antonia; Mannem, Siva; Silbermann, Rebecca; Lunning, Matthew; Chu, Michael; Milner, Carter; Harroff, Allyson; Graham, Mark; Shao, Spencer; Dodlapati, Jyothi; de Larrea, Carlos Fernández; Klein, Leonard; Kuzma, Charles; Fonseca, Rafael; Azaceta, Gemma; Granell, Miquel; Martinez-Chamorro, Carmen; Balaraman, Rama; Silva, Carlos; Chinea, Anabelle; Costello, Caitlin; Kambhampati, Suman; Lewis, DeQuincy; Grossbard, Michael; Yost, Kathleen; Robles, Robert; Sebag, Michael; Harris, Wayne; Ngaiza, Justinian; Bar, Michael; Shieh, Marie; Min, Fredrick; Onitilo, Adedayo; Volterra, Fabio; Wachsman, William; Yalamachili, Madhuri; Abella, Eugenia; Anderson, Larry; Bargay, Joan; Hassoun, Hani; Hsu, Gerald; Kaya, Hakan; Menter, Alex; Patel, Dilip; Richards, Donald; Solomon, William; Anderson, Robert; Chandra, Sumeet; Conde, Miguel; Girnius, Saulias; Matkiwsky, May; Krsnik, Isabel; Kumar, Shaji; Oriol, Albert; Rodríguez, Paula; Roy, Vivek; Srinivas, Shanti; Steis, Ronald; Christofferson, Austin W.; Nasser, Sara; Aldrich, Jessica L.; Legendre, Christophe; Benard, Brooks; Miller, Chase; Turner, Bryce; Kurdoglu, Ahmet; Washington, Megan; Yellapantula, Venkata; Adkins, Jonathan R.; Cuyugan, Lori; Boateng, Martin; Helland, Adrienne; Kyman, Shari; McDonald, Jackie; Reiman, Rebecca; Stephenson, Kristi; Tassone, Erica; Blanski, Alex; Livermore, Brianne; Kirchhoff, Meghan; Rohrer, Daniel C.; D'Agostino, Mattia; Gamella, Manuela; Collison, Kimberly; Stumph, Jennifer; Kidd, Pam; Donnelly, Andrea; Zaugg, Barbara; Toone, Maureen; McBride, Kyle; DeRome, Mary; Rogers, Jennifer; Craig, David; Liang, Winnie S.; Gutierrez, Norma C.; Jewell, Scott D.; Carpten, John; Anderson, Kenneth C.; Cho, Hearn Jay; Auclair, Daniel; Lonial, Sagar; Keats, Jonathan J.
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials
2018-01-01 D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F.
Designing a strong bridge to CAR-T cells with bispecifics
2025-01-01 Gay, Francesca; D'Agostino, Mattia
Determining treatment intensity in elderly patients with multiple myeloma
2018-01-01 Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma
2021-01-01 Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
| Additional copies of 1q negatively impact the outcome of multiple myeloma patients and induce transcriptomic deregulation in malignant plasma cells | 2024 | D'Agostino, Mattia; Rota-Scalabrini, Delia; Belotti, Angelo; Bertamini, Luca; Arigoni, Maddalena; De Sabbata, Giovanni; Pietrantuono, Giuseppe; Pascarella, Anna; Tosi, Patrizia; Pisani, Francesco; Pescosta, Norbert; Ruggeri, Marina; Rogers, Jennifer; Olivero, Martina; Garzia, Mariagrazia; Galieni, Piero; Annibali, Ombretta; Monaco, Federico; Liberati, Anna Marina; Palmieri, Salvatore; Stefanoni, Paola; Zamagni, Elena; Bruno, Benedetto; Calogero, Raffaele Adolfo; Boccadoro, Mario; Musto, Pellegrino; Gay, Francesca | |
| Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies | 2024 | Richardson, Paul G.; Perrot, Aurore; Mikhael, Joseph; Martin, Thomas; Beksac, Meral; Spicka, Ivan; Capra, Marcelo; D'Agostino, Mattia; Sonneveld, Pieter; Bisht, Kamlesh; Fukao, Taro; Zhang, Rick; Tada, Keisuke; Tekle, Christina; Macé, Sandrine; Klippel, Zandra; van de Velde, Helgi; Moreau, Philippe | |
| Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better? | 2020 | D'Agostino M.; Raje N. | |
| Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen? | 2020 | D'Agostino M.; Mina R.; Gay F. | |
| Anticorpi monoclonali bispecifici nel trattamento del mieloma multiplo | 2019 | Mattia D'Agostino; Mario Boccadoro | |
| Bortezomib-melphalan-prednisone versus lenalidomide-dexamethasone in elderly patients with multiple myeloma: the Real MM phase IV trial | 2025 | Bringhen, Sara; Cani, Lorenzo; Giuliani, Nicola; Mangiacavalli, Silvia; Benevolo, Giulia; Antonioli, Elisabetta; Zambello, Renato; Ria, Roberto; Vincelli, Iolanda Donatella; Ronconi, Sonia; More, Sonia; Falcone, Antonietta Pia; Allegra, Alessandro; D'Agostino, Mattia; Evangelista, Andrea; Capra, Andrea; Sciorsci, Elisa; Curci, Paola; Tosi, Patrizia; Liberati, Anna Marina; Cafro, Anna Maria; Belotti, Angelo; Patriarca, Francesca; Mannina, Donato; Mancuso, Katia; Cattel, Francesco; Ciccone, Giovannino; Bruno, Benedetto; Boccadoro, Mario; Larocca, Alessandra | |
| Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial | 2021 | Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario | |
| Carfilzomib–lenalidomide–dexamethasone versus lenalidomide–dexamethasone in patients with newly diagnosed myeloma ineligible for autologous stem-cell transplantation (EMN20): a randomised, open-label, multicentre, phase 3 trial | 2025 | Bringhen, Sara; Cani, Lorenzo; Antonioli, Elisabetta; Derudas, Daniele; Fazio, Francesca; Larocca, Alessandra; Ronconi, Sonia; Cellini, Claudia; Falcone, Antonietta Pia; Accardi, Fabrizio; Liberati, Anna Marina; Galieni, Piero; Belotti, Angelo; Cafro, Anna Maria; Ria, Roberto; Benevolo, Giulia; Vincelli, Iolanda Donatella; Mannina, Donato; Lotti, Flavia; Bruno, Benedetto; Marasco, Vincenzo; Mazza, Rita; Tosi, Patrizia; Rivolti, Elena; Boccadoro, Mario; D'Agostino, Mattia | |
| CD38 as an immunotherapeutic target in multiple myeloma | 2018 | Bonello F.; D'Agostino M.; Moscvin M.; Cerrato C.; Boccadoro M.; Gay F. | |
| Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino | 2019 | Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro | |
| Circulating tumor cells predict myeloma outcomes in patients treated with daratumumab, bortezomib, lenalidomide, and dexamethasone | 2025 | Bertamini, Luca; Fokkema, Cathelijne; Rodriguez-Otero, Paula; van Duin, Mark; Terpos, Evangelos; D'Agostino, Mattia; van der Velden, Vincent H.J.; van de Donk, Niels W.C.J.; Delforge, Michel; Driessen, Christoph; Hajek, Roman; Einsele, Hermann; Vangsted, Annette Juul; Vieyra, Diego; Attar, Ricardo M; Sitthi-Amorn, Anna; Carson, Robin; Schjesvold, Fredrik; Robak, Pawel; Beksac, Meral; Spencer, Andrew; Broijl, Annemiek; Cupedo, Tom; Moreau, Philippe; Boccadoro, Mario; Sonneveld, Pieter | |
| Clinical and pharmacologic features of monoclonal antibodies and checkpoint blockade therapy in multiple myeloma | 2019 | D'Agostino M.; Gazzera G.; Cetani G.; Bringhen S.; Boccadoro M.; Gay F. | |
| Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma | 2020 | Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A. | |
| Clinicians’ Perspectives and Methodological Application of Fluorescence in Situ Hybridization (FISH) to Define Cytogenetic Risk in Multiple Myeloma: An Italian, Real-World, Survey-Based Report from the European Myeloma Network (EMN) Italy | 2025 | Cani, Lorenzo; Petrucci, Maria Teresa; Mancuso, Katia; Zambello, Renato; Paris, Laura; Aquino, Sara; Lotti, Flavia; Vassallo, Francesco; Pescosta, Norbert; Quaresima, Micol; Tosi, Patrizia; Vincelli, Iolanda Donatella; Ronconi, Sonia; Giuliani, Nicola; Pisani, Francesco; Luppi, Mario; Rizzi, Rita; Mazza, Rita; Rota-Scalabrini, Delia; Cellini, Claudia; Mangiacavalli, Silvia; Pietrantuono, Giuseppe; Pioltelli, Maria Luisa; Falcone, Antonietta Pia; Antonioli, Elisabetta; Belotti, Angelo; Morè, Sonia; Bruno, Benedetto; Boccadoro, Mario; D'Agostino, Mattia | |
| Comprehensive molecular profiling of multiple myeloma identifies refined copy number and expression subtypes | 2024 | Skerget, Sheri; Penaherrera, Daniel; Chari, Ajai; Jagannath, Sundar; Siegel, David S.; Vij, Ravi; Orloff, Gregory; Jakubowiak, Andrzej; Niesvizky, Ruben; Liles, Darla; Berdeja, Jesus; Levy, Moshe; Wolf, Jeffrey; Usmani, Saad Z.; null, null; Rifkin, Robert; Meehan, Kenneth; Benson, Don; Zonder, Jeffrey; Ascensao, Joao; Gasparetto, Cristina; Hernández, Miguel; Trudel, Suzanne; Dakhil, Shaker; Bahlis, Nizar; Paganini, Juan Vazquez; Rios, Pablo; Sampol, Antonia; Mannem, Siva; Silbermann, Rebecca; Lunning, Matthew; Chu, Michael; Milner, Carter; Harroff, Allyson; Graham, Mark; Shao, Spencer; Dodlapati, Jyothi; de Larrea, Carlos Fernández; Klein, Leonard; Kuzma, Charles; Fonseca, Rafael; Azaceta, Gemma; Granell, Miquel; Martinez-Chamorro, Carmen; Balaraman, Rama; Silva, Carlos; Chinea, Anabelle; Costello, Caitlin; Kambhampati, Suman; Lewis, DeQuincy; Grossbard, Michael; Yost, Kathleen; Robles, Robert; Sebag, Michael; Harris, Wayne; Ngaiza, Justinian; Bar, Michael; Shieh, Marie; Min, Fredrick; Onitilo, Adedayo; Volterra, Fabio; Wachsman, William; Yalamachili, Madhuri; Abella, Eugenia; Anderson, Larry; Bargay, Joan; Hassoun, Hani; Hsu, Gerald; Kaya, Hakan; Menter, Alex; Patel, Dilip; Richards, Donald; Solomon, William; Anderson, Robert; Chandra, Sumeet; Conde, Miguel; Girnius, Saulias; Matkiwsky, May; Krsnik, Isabel; Kumar, Shaji; Oriol, Albert; Rodríguez, Paula; Roy, Vivek; Srinivas, Shanti; Steis, Ronald; Christofferson, Austin W.; Nasser, Sara; Aldrich, Jessica L.; Legendre, Christophe; Benard, Brooks; Miller, Chase; Turner, Bryce; Kurdoglu, Ahmet; Washington, Megan; Yellapantula, Venkata; Adkins, Jonathan R.; Cuyugan, Lori; Boateng, Martin; Helland, Adrienne; Kyman, Shari; McDonald, Jackie; Reiman, Rebecca; Stephenson, Kristi; Tassone, Erica; Blanski, Alex; Livermore, Brianne; Kirchhoff, Meghan; Rohrer, Daniel C.; D'Agostino, Mattia; Gamella, Manuela; Collison, Kimberly; Stumph, Jennifer; Kidd, Pam; Donnelly, Andrea; Zaugg, Barbara; Toone, Maureen; McBride, Kyle; DeRome, Mary; Rogers, Jennifer; Craig, David; Liang, Winnie S.; Gutierrez, Norma C.; Jewell, Scott D.; Carpten, John; Anderson, Kenneth C.; Cho, Hearn Jay; Auclair, Daniel; Lonial, Sagar; Keats, Jonathan J. | |
| Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials | 2018 | D'Agostino M.; De Paoli L.; Conticello C.; Offidani M.; Ria R.; Petrucci M.T.; Spada S.; Marcatti M.; Catalano L.; Gilestro M.; Guglielmelli T.; Baldini L.; Gamberi B.; Rizzi R.; De Sabbata G.; Di Renzo N.; Patriarca F.; Pezzatti S.; Siniscalchi A.; Ribolla R.; Palumbo A.; Montefusco V.; Nagler A.; Boccadoro M.; Gay F. | |
| Designing a strong bridge to CAR-T cells with bispecifics | 2025 | Gay, Francesca; D'Agostino, Mattia | |
| Determining treatment intensity in elderly patients with multiple myeloma | 2018 | Salvini M.; D'Agostino M.; Bonello F.; Boccadoro M.; Bringhen S. | |
| Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma | 2021 | Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara |